XTL Biopharma (XTLB) Announces Receipt of NASDAQ Notification Regarding Minimum Bid Requirements

November 9, 2016 1:27 PM EST
Get Alerts XTLB Hot Sheet
Trade XTLB Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) today announced that it received a notice from The NASDAQ Stock Market ("NASDAQ") that the Company is not in compliance with NASDAQ's Listing Rule 5450(a)(1) because the minimum bid price of the Company's American Depositary Shares ("ADSs") has closed below US$1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company's ADSs on The Nasdaq Capital Market.

The Company has 180 days, or until May 8, 2017, to achieve compliance with the minimum bid price requirement. To regain compliance, the minimum bid price of the Company's ADSs must meet or exceed US$1.00 per share for a minimum of 10 consecutive business days during this 180-day grace period.

If the Company does not regain compliance with the rule by May 8, 2017, the Company may be eligible for an additional 180 day compliance period.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News

Add Your Comment